Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Takeda Pharma to build a new pharma manufacturing plant in Hikari City
The company is planning to commence the construction work from October 2010 and is expected to start operations in the fiscal 2012. In the new plant, the company
The company is planning to commence the construction work from October 2010 and is expected to start operations in the fiscal 2012. In the new plant, the company
Patients with COPD using the new Onbrez Breezhaler were also able to reduce their use of rescue medication compared to those using salmeterol, a widely prescribed drug in
Chi-Med said that the product is produced in Switzerland under an exclusive supply agreement with an independent supplier and has completed the China importation and certification process with
Taiho Pharma said that Abraxane features improved efficacy and safety as well as easier administration compared to solvent-based paclitaxel. Originally, Abraxane was developed by Abraxis BioScience as a
The 12-week, randomised, double-blind, multicenter Phase III study demonstrated that Lixisenatide was safe and well tolerated in patients with type 2 diabetes. The trial result suggested that Lixisenatide
The patent covers compounds including Triolex and formulations that contain the drug or the other claimed compounds. Harbor BioSciences said that Triolex is a compound for the treatment
The service utilises short tandem repeat (STR) profiling, a widely used technique established in forensic science. In a quest to discover new therapeutic drugs and drug targets, cell
For the third quarter ended 31 July 2010, Renhuang Pharma’s net income grew 115.8% to $1.5m, or $0.04 per diluted share, from $0.7m, or $0.02 per diluted share
Under the 4-year agreement, the KIF6 test kit manufactured by Celera, will be distributed by Abbott in the European Union and other geographic areas excluding the US. The
Most recently, Biller has worked for Novartis as the vice president and head of global discovery chemistry at the Novartis Institutes for BioMedical Research (NIBR). Befor joining Novartis,